Genor Biopharma Holdings Limited (6998.HK)
HKD 1.66
(-5.68%)
HKD 1.66
(-5.68%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.33 CNY | 8.28% |
| 2022 | -1.45 CNY | 17.14% |
| 2021 | -1.75 CNY | 85.85% |
| 2020 | -12.37 CNY | -1034.86% |
| 2019 | -1.09 CNY | -81.67% |
| 2018 | -0.60 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.12 CNY | 0.0% |
| 2024 Q1 | -0.12 CNY | 69.23% |
| 2023 Q2 | -0.27 CNY | 0.0% |
| 2023 Q4 | -0.39 CNY | 0.0% |
| 2023 Q3 | -0.39 CNY | -44.44% |
| 2023 FY | - CNY | 8.28% |
| 2023 Q1 | -0.27 CNY | 15.63% |
| 2022 Q3 | -0.32 CNY | 21.95% |
| 2022 Q2 | -0.41 CNY | 0.0% |
| 2022 Q1 | -0.41 CNY | 12.77% |
| 2022 FY | - CNY | 17.14% |
| 2022 Q4 | -0.32 CNY | 0.0% |
| 2021 Q1 | -0.41 CNY | 91.68% |
| 2021 FY | - CNY | 85.85% |
| 2021 Q4 | -0.47 CNY | 0.0% |
| 2021 Q3 | -0.47 CNY | -14.63% |
| 2021 Q2 | -0.41 CNY | 0.0% |
| 2020 Q1 | -0.30 CNY | 0.0% |
| 2020 Q4 | -4.93 CNY | 0.0% |
| 2020 Q3 | -4.93 CNY | -508.64% |
| 2020 Q2 | -0.81 CNY | -170.0% |
| 2020 FY | - CNY | -1034.86% |
| 2019 FY | - CNY | -81.67% |
| 2019 Q1 | -0.16 CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 12081.982% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 73988.889% |